Medication Error Possible if Incompatible Autoinjector Used to Administer MS Drug
The FDA has issued a safety communication regarding cross-compatibility issues with autoinjector devices that are optional for use with glatiramer acetate injection.
Stay updated with breaking news from Acetate Injection. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The FDA has issued a safety communication regarding cross-compatibility issues with autoinjector devices that are optional for use with glatiramer acetate injection.
Dublin, Aug. 05, 2022 (GLOBE NEWSWIRE) -- The "Fertility Drugs Global Market Report 2022, Gender, Route of Administration, Type Of Drug, Distribution...
/PRNewswire/ -- The "Fertility Drugs Global Market Report 2022, Gender, Route of Administration, Type Of Drug, Distribution Channel" report has been added to...
Leuprolide Acetate for injection is indicated for the treatment used to treat the symptoms associated with advanced prostate cancer by way of Palliative treatment of advanced prostatic cancer.
Uniindia: Hyderabad, June 7 (UNI) Aurobindo Pharma Ltd on Tuesday announced that its wholly owned subsidiary, Eugia Pharma Specialties Ltd, has received a final approval from the US Food and Drug Administration (USFDA) to manufacture and market Leuprolide Acetate Injection, 14 mg/2.8 mL MDV (Kit).